| 000 | 01505nam a2200265Ia 4500 | ||
|---|---|---|---|
| 003 | MX-MdCICY | ||
| 005 | 20250625140619.0 | ||
| 040 | _cCICY | ||
| 090 | _aB-9814 | ||
| 245 | 1 | 0 | _aCells, scaffolds, and molecules for myocardial tissue engineering |
| 490 | 0 | _vPharmacology & Therapeutics, 105(2), p.151-163, 2005 | |
| 520 | 3 | _aUnlike heart valves or blood vessels, heart muscle has no replacement alternatives. The most challenging goal in the field of cardiovascular tissue engineering is the creation/ regeneration of an engineered heart muscle. Recent advances in methods of stem cell isolation, culture in bioreactors, and the synthesis of bioactive materials promise to create engineered cardiac tissue ex vivo. At the same time, new approaches are conceived that explore ways to induce tissue regeneration after injury. The purpose of our review is to describe the principles, status, and challenges of myocardial tissue engineering with emphasize on the concept of in situ cardiac tissue engineering and regeneration | |
| 650 | 1 | 4 | _aBIOMATERIAL |
| 650 | 1 | 4 | _aCELL |
| 650 | 1 | 4 | _aHEART |
| 650 | 1 | 4 | _aSCAFFOLD |
| 650 | 1 | 4 | _aTISSUE ENGINEERING |
| 650 | 1 | 4 | _aTRANSPLANTATION |
| 700 | 1 | 2 | _aLeora, J. |
| 700 | 1 | 2 | _aAmsalema, Y. |
| 700 | 1 | 2 | _aCohen, S. |
| 856 | 4 | 0 |
_uhttps://drive.google.com/file/d/1Y9FABNmU6NN1wDVS1FN4DnF1qn20Zp0b/view?usp=drivesdk _zPara ver el documento ingresa a Google con tu cuenta: @cicy.edu.mx |
| 942 |
_2Loc _cREF1 |
||
| 008 | 250602s9999 xx |||||s2 |||| ||und|d | ||
| 999 |
_c44060 _d44060 |
||